StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ASB.AX$3.85-2.78%
Fair $3.85+0.0%

ASB.AX

Austal Limited

Industrials / Aerospace & DefenseASX

$3.85

-0.11 (-2.78%)

Fairly Valued+0.0%Fair Value $3.85Fund rank 28/100 · Data gapFallback financials|
SA 50/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-41.9M · quality 50.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · ASB.AXLocal privado en este navegador · Austal Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.6B

P/E

16.7x

↓

EV/EBITDA

5.8x

↓

ROE

6.9%

↑

Gross Margin

12.6%

↓

Debt/Equity

0.20

↓
52-Week Range$4
$4$9

TradingView lightweight chart

ASB.AX price, volumen y niveles de valoración

Último $3.850Periodo +44.8%
Fair value: $3.850

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.5%

FCF CAGR

—

FCF margin

11.6%

FCF / Net income

2.35x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.82B · net income $89.7M · FCF $210.7M

2022-FY → 2025-FY

Gross margin

12.6%-3.5% pts

Operating margin

0.4%-4.1% pts

Net margin

4.9%-0.6% pts

FCF margin

11.6%+17.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.82B$1.82B$1.47B$1.59B$1.43B
Net Income$89.7M$89.7M$14.9M$-13.8M$79.6M
EBITDA$199.8M$199.8M$127.6M$56.8M$165.5M
EPS0.230.230.04-0.040.22
Gross Margin12.6%12.6%11.7%6.3%16.1%
Operating Margin0.4%0.4%-6.2%-5.6%4.5%
Net Margin4.9%4.9%1.0%-0.9%5.6%
Balance Sheet
Debt/Equity0.200.200.280.250.19
Current Ratio1.691.69———
Cash Flow
Free Cash Flow$210.7M$210.7M$-83.0M$-41.9M$-79.6M
Returns
ROE6.9%6.9%1.5%-1.5%6.4%
Valuation
P/E16.7416.7461.46—11.42
EV/EBITDA5.845.848.0018.265.45
P/B1.131.130.911.030.74
Growth & Yield
Revenue Growth24.1%24.1%-7.3%10.9%—
EPS Growth468.3%468.3%207.9%-117.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

13.6%

razonable

EPS terminal req.

$0.34

Spread vs growth

454.7%

5Y implied EPS CAGR

12.1%

razonable

EPS terminal req.

$0.41

Spread vs growth

456.1%

10Y implied EPS CAGR

11.1%

razonable

EPS terminal req.

$0.67

Spread vs growth

457.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -34.7%

Total return

-34.7%

Start / end P/E

143.9x → 16.5x

EPS bridge

0.04 → 0.23

Residual

-414.5%

EPS growth+468.3%
Multiple rerating-88.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-414.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.